Brooks Jackson, MD, MBA
Dean, Medical School
Dean, Medical School
Vice President, Office of the Vice President for Health Sciences
Principal Investigator, of International Maternal Pediatric Adolescent AIDS Clinical Trials NetworkChair of the Blood Products Advisory Committee for the Food and Drug Administration
Chair of the Blood Products Advisory Committee for the Food and Drug Administration
Dartmouth College, Hanover, NH, 1982
University of Minnesota (Department of Laboratory Medicine, Clinical Pathology only), 1982 - 1985
University of Minnesota Hospitals, Blood Bank Fellow, Department of Laboratory Medicine and Pathology, 1984 - 1985
Dartmouth College, Hanover, NH (Master's in Business Administration), 1977
Kenyon College, Gambier, Ohio (History), 1975
Awards & Recognition
An internationally recognized researcher in HIV diagnostics, prevention and treatment, Dr. Jackson and his colleagues revolutionized HIV prevention in developing countries and published approximately 200 peer-reviewed papers about HIV prevention and treatment research conducted in the United States, Uganda and China. He is also the principal investigator of the $500 million NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. Jackson’s work resulted in new drug development and a project to prevent neonatal HIV transmission. The method has saved thousands of infants from starting life with HIV infection.
Peer Reviewed Publications
- Amukele TK, Schroeder LF,Jackson JB,Elbireer A. Most clinical laboratory testing in Kampala occurs in high-volume, high-quality laboratories or low-volume, low-quality laboratories. A tale of two cities. Am J Clin Pathol. 2015 Jan;143(1):50-6. doi: 10.1309/AJCPCYA54DWZQPQT.
- Lucas GM, Young A, Donnell D, Richardson P, Aramattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D. Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug Alcohol Depend. 2014 Sep 1; 0: 139–145.
- Yang W, Shah P, Eshghi ST, Yang S, Ao M, Rubin A, Jackson JB, Zhang H. Glycoform analysis of recombinant and human deficiency virus envelope gp120 via higher energy C-trap dissociation and spectral-mapping algorithm. Anal Chem. 2014 Jul 15;86(14):6959-67. doi: 10.1021/ac500876p. Epub 2014 Jul 2.
- Jackson JB, Wei L, Liping F, Aramrattana A, Celantano D, Walshe L, Xing Y, Richardson P, Jun Ma, Beauchamp G, Ruan Y, Ma L, Metzger, Shao Y. Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs (PWIDs) in China and Thailand. Hepatitis research and treatment 2014;296958.
- Caturegli P, McCarthy E, Jackson JB, Hruban RH. The pathology residency program of the Johns Hopkins University School of Medicine: A model of its kind. (in press)
- Yang W, Zhou J-Y, Chen L, Ao Minghui, Sun S, Aiyetan P, Simmons A, Zhang H, Jackson JB. Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma. Clinical Proteomics 2014;11:9.
- Kaleebu P, Njai H, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Kityo C, Emel L, Musoke P, Fowler MG, Ou S-S, Jackson B, Guay L, Allen M, Zwerski S, Andrew P, Cao H for the HPTN 027 protocol team. Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1 infected women in Uganda (HPTN 027). J Acquir Immune Defic Syndr 2014;65:268-277.
- Fowler MG, Coovadia H, Herron CM, Maldonado B, Chipato T, Moodley D, Musoke P, Azire J, Manji K, Stanix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, George K, Andrew P, Zwerski S, Mofenson L, Jackson JB for the HPTN 046 protocol team. J Acquir Immune Defic Syndr 2014;65:366-374.
- Owor M, Mwatha A, Donnell D, Musoke P, Mmiro F, Jackson JB, Fowler MG, Allen M, Guay LA. Long term follow-up of children in HIVNET 012: Five year growth and survival. J Acquir Immune Defic Syndr 2013;64:464-471.
- Smith HM, Shirey RS, Thoman SK, Jackson JB. Prevalence of clinically significant red cell alloantibodies in pregnant patients at a large tertiary care facility. (in press)
- Jackson JB: Genetics in the diagnosis and prevention of viral diseases. In: Clinical Aspects of Genetic Engineering. Arlington, American Association of Blood Banks, 1987, pp. 1-18.
- Peterson PK, Sharp BM, Gekker G, Jackson B, Balfour HH, Jr. Opiates, human peripheral blood mononuclear cells, and HIV. In: Drugs of abuse, immunity, and immunodeficiency. pp 171-178. Ed. Herman Friedman, Steven Specter, and Thomas W. Klein. Plenum Press, New York, 1991.
- Institute of Medicine. Curran J, Debas H, Solomon B, Blower S, Jackson JB, Kombe G, Mugyenyi P, Padayachee N, Padian N, Reddy P, Richman D, Walker B. Scaling up treatment for the Global AIDS Pandemic: Challenges and Opportunities. The National Academies Press. Washington DC. 2004.
Pathology Lab;University of Minnesota Medical Center
American Board of Pathology, Clinical Pathology and Blood Banking/Transfusion Medicine
Transfusion Medicine; Pheresis; Transfusion-transmitted diseases; HIV diagnostics, prevention and treatment